These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 37280056

  • 1. Seasonal variation of serum potassium and related prescription pattern: an ecological time series.
    Thayakaran R, Hotham R, Gokhale KM, Adderley NJ, Chandan JS, Nirantharakumar K.
    J Clin Pathol; 2024 Sep 19; 77(10):663-668. PubMed ID: 37280056
    [Abstract] [Full Text] [Related]

  • 2. Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study.
    Mahmoudpour SH, Asselbergs FW, Souverein PC, de Boer A, Maitland-van der Zee AH.
    Br J Clin Pharmacol; 2018 Oct 19; 84(10):2365-2372. PubMed ID: 29943849
    [Abstract] [Full Text] [Related]

  • 3. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr 19; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

  • 4. Patient- and physician-related risk factors for hyperkalaemia in potassium-increasing drug-drug interactions.
    Eschmann E, Beeler PE, Kaplan V, Schneemann M, Zünd G, Blaser J.
    Eur J Clin Pharmacol; 2014 Feb 19; 70(2):215-23. PubMed ID: 24150532
    [Abstract] [Full Text] [Related]

  • 5. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Jan 19; 16(1):55-64. PubMed ID: 16470693
    [Abstract] [Full Text] [Related]

  • 6. Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors.
    Mahmoudpour SH, Asselbergs FW, de Keyser CE, Souverein PC, Hofman A, Stricker BH, de Boer A, Maitland-van der Zee AH.
    Int J Clin Pharm; 2015 Dec 19; 37(6):1095-103. PubMed ID: 26159317
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
    Bakris GL, Weir MR.
    Arch Intern Med; 2000 Mar 13; 160(5):685-93. PubMed ID: 10724055
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Laboratory monitoring to reduce adverse drug-related events: a mixed methods study.
    Harrison TN, Reynolds K, Hahn EE, Munoz-Plaza CE, Yi DK, Fischer H, Luong TQ, Sim JJ, Brettler J, Handler J, Mittman BS, Singh H, Kanter MH, Danforth KN.
    J Manag Care Spec Pharm; 2022 Jan 13; 28(1):16-25. PubMed ID: 34949121
    [Abstract] [Full Text] [Related]

  • 11. ACE-inhibitor or AT2-antagonist therapy of renal transplant recipients is associated with an increase in serum potassium concentrations.
    Mitterbauer C, Heinze G, Kainz A, Kramar R, Hörl WH, Oberbauer R.
    Nephrol Dial Transplant; 2008 May 13; 23(5):1742-6. PubMed ID: 18234845
    [Abstract] [Full Text] [Related]

  • 12. Impact of Renin-Angiotensin Aldosterone System Inhibition on Serum Potassium Levels among Peritoneal Dialysis Patients.
    Ribeiro SC, Figueiredo AE, Barretti P, Pecoits-Filho R, de Moraes TP, BRAZPD Investigators.
    Am J Nephrol; 2017 May 13; 46(2):150-155. PubMed ID: 28738355
    [Abstract] [Full Text] [Related]

  • 13. Use of Renin-Angiotensin System Blockers Increases Serum Potassium in Anuric Hemodialysis Patients.
    Movilli E, Camerini C, Gaggia P, Zubani R, Cancarini G.
    Am J Nephrol; 2018 May 13; 48(2):79-86. PubMed ID: 30071530
    [Abstract] [Full Text] [Related]

  • 14. Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments.
    Hirai T, Yamaga R, Fujita A, Itoh T.
    J Clin Pharm Ther; 2018 Dec 13; 43(6):829-835. PubMed ID: 29908131
    [Abstract] [Full Text] [Related]

  • 15. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA.
    Cardiovasc Ther; 2012 Jun 13; 30(3):e156-66. PubMed ID: 21883995
    [Abstract] [Full Text] [Related]

  • 16. Adequate intake of potassium does not cause hyperkalemia in hypertensive individuals taking medications that antagonize the renin angiotensin aldosterone system.
    Malta D, Arcand J, Ravindran A, Floras V, Allard JP, Newton GE.
    Am J Clin Nutr; 2016 Oct 13; 104(4):990-994. PubMed ID: 27581475
    [Abstract] [Full Text] [Related]

  • 17. Association of Albuminuria Levels With the Prescription of Renin-Angiotensin System Blockade.
    Qiao Y, Shin JI, Chen TK, Sang Y, Coresh J, Vassalotti JA, Chang AR, Grams ME.
    Hypertension; 2020 Dec 13; 76(6):1762-1768. PubMed ID: 32981368
    [Abstract] [Full Text] [Related]

  • 18. [Assessment of the utilization of angiotensin receptor blockers in hypertension].
    Peña Cabia S, Ricote Lobera I, Santos Mena B, Hidalgo Correas FJ, Climent Florez B, García Díaz B.
    Farm Hosp; 2013 Dec 13; 37(5):394-8. PubMed ID: 24128102
    [Abstract] [Full Text] [Related]

  • 19. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
    Wang PT, Huang YB, Lin MY, Chuang PF, Hwang SJ.
    Kaohsiung J Med Sci; 2012 Sep 13; 28(9):477-83. PubMed ID: 22974666
    [Abstract] [Full Text] [Related]

  • 20. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations.
    Parikh RV, Nash DM, Brimble KS, Markle-Reid M, Tan TC, McArthur E, Khoshniat-Rad F, Sood MM, Zheng S, Pravoverov L, Nesrallah GE, Garg AX, Go AS.
    Circ Cardiovasc Qual Outcomes; 2020 Sep 13; 13(9):e006415. PubMed ID: 32873054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.